Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...

Though they have taken the world by storm, GLP-1 drugs like semaglutide — sold as Ozempic ... struggled to package GLP-1 agonists and other peptide-based drugs into pill form because peptides ...

Expert Rev Endocrinol Metab. 2013;8(3):247-259. It is unclear to what degree these specific changes in CV parameters and risk factors play in overall clinical outcomes. As earlier outlined, short ...